Recent Insider Transactions - Prelude Therapeutics (NASDAQ: PRLD)

Company

Name / Role

Date

Type

Price

# Shares

Value

Balance

NASDAQ PRLD Prelude Therapeutics

Lim Bryant David / officer: CLO, Interim CFO, Corp Sec.

12/19/2024

Buy

$0.91

25,000

$23K

27,400

NASDAQ PRLD Prelude Therapeutics

Vaddi Krishna / director, officer: CEO

12/18/2024

Buy

$0.93

100,000

$93K

1.17M

NASDAQ PRLD Prelude Therapeutics

Vaddi Krishna / director, officer: CEO

12/19/2024

Buy

$0.89

6,888

$6K

127,553